PIM
PBYI icon

Partner Investment Management’s Puma Biotechnology PBYI Stock Holding History

Partner Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-33,866
Closed -$365K – 58
2019
Q3 		$365K Buy
33,866
+6,299
+23% +$68K 0.63% 48
2019
Q2 		$350K Buy
27,567
+74
+0.3% +$1.7K 0.37% 59
2019
Q1 		$1.07M Buy
+27,493
New +$840K 1.23% 28
2018
Q4 		– Sell
-25,676
Closed -$1.18M – 112
2018
Q3 		$1.18M Buy
25,676
+1,982
+8% +$95.6K 0.9% 44
2018
Q2 		$1.4M Sell
23,694
-3,460
-13% -$201K 1.13% 25
2018
Q1 		$1.85M Buy
27,154
+785
+3% +$58.8K 2% 14
2017
Q4 		$2.61M Buy
26,369
+5,075
+24% +$568K 3% 4
2017
Q3 		$2.55M Sell
21,294
-7,988
-27% -$743K 2.42% 7
2017
Q2 		$2.56M Buy
29,282
+11,668
+66% +$653K 3.44% 4
2017
Q1 		$655K Sell
17,614
-679
-4% -$24.8K 0.8% 50
2016
Q4 		$562K Buy
+18,293
New +$791K 0.74% 46
2016
Q3 		– Sell
-22,740
Closed -$677K – 101
2016
Q2 		$677K Buy
+22,740
New +$711K 1.11% 40

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Partner Investment Management's PBYI Position: Q4 2019 in Review

Partner Investment Management sold out of Puma Biotechnology (PBYI) in Q4 2019, closing a stake of 33,866 shares — an estimated $365K sold.

Partner Investment Management first reported a position in PBYI in Q2 2016 and held it in 12 quarters. The position peaked at $2.61M in Q4 2017. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • Partner Investment Management reported no remaining Puma Biotechnology position as of Q4 2019 after selling out during the quarter.
  • Partner Investment Management sold 33,866 Puma Biotechnology shares in Q4 2019, an estimated $365K.
  • Partner Investment Management first reported a position in Puma Biotechnology in Q2 2016 and held it in 12 quarters.
  • Partner Investment Management's Puma Biotechnology position peaked at $2.61M in Q4 2017.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.